Inflation Reduction Act Imposes Prescription Drug Pricing Reforms
Healthcare Law Insights blog
NOVEMBER 8, 2022
The Secretary is required to negotiate prices for 10 single-source drugs, beginning in 2026 and increasing each subsequent year through 2029, when 20 single-source drugs will be chosen for pricing negotiation. Small Biotech” drugs are also excluded until 2029. What this means to you.
52 
Let's personalize your content